Ken Griffin's position in 10x Genomics is currently worth $65 Million. That's 0.08% of their equity portfolio (333rd largest holding). The investor owns 1.29% of the outstanding 10x Genomics stock. The first 10x Genomics trade was made in Q3 2019. Since then Ken Griffin bought shares six more times and sold shares on seven occasions. The stake costed the investor $43.4 Million, netting the investor a gain of 50% so far.